Clinical TrialsSearch results
Number of results: 230
Other
- A non-randomized confirmatory study of Limited Surgical Resection for Peripheral Early Lung Cancer Defined with Thoracic Thin-section Computed Tomography (JCOG0804/WJOG4507L)
- small (2 cm or less) peripheral radiological non-invasive lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-05-26
Completed
- A pharmacokinetics study of dantrolene sodium hydrate in patients with moderately to severely reduced kidney function
- CKD
- Uchinoumi Hitoshi
- 2022-12-02
Other
- A phase 2 neoadjuvant chemotherapy of Irinotecan (CPT-11) plus Nedaplatin (NDP) for stage 1b2 or 2 cervical cancer of the uterine cervix
- stage 1b2/2 cervical cancer
- Japanese Gynecologic Oncology Group
- 2006-12-21
Recruiting
- A Phase 2, Randomized, Placebo-controlled, Double-Blind, Parallel Group, Multi-Center Study to Evaluate Efficacy and Safety of M127101 in Subjects with Nasal polyp associated with Eosinophilic Chronic Rhinosinusitis
- Nasal polyp associated with Eosinophilic Chronic Rhinosinusitis
- Nishiura Tomoyuki
- 2024-05-10
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase I/II Study of Vinorelbine plus Trastuzumab in Patients with Advanced/Recurrent Breast Cancer Previously Treated with Anthracyclines and Taxanes
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2006-07-13
Other
- A Phase II Study of carboplatin plus paclitaxel for advanced thymic cancer
- Thymic cancer
- West Japan Oncology Group
- 2008-09-08
Other
- A Phase II study of M119102 for alopecia areata
- Alopecia Areata
- Tomoyuki Nishiura
- 2022-12-23
Other
- A phase III randomised trial of lobectomy versus limited resection (segmentectomy) for small (2 cm or less) peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)
- small (2 cm or less) peripheral non-small cell lung cancer
- Japan Clinical Oncology Group(JCOG)
- 2009-08-10
Recruiting
- A Phase III Randomised, Double-blind, Multicentre Study to Compare the Efficacy, Safety, Pharmacokinetics, and Immunogenicity between SB27 (proposed pembrolizumab biosimilar) and Keytruda in Subjects with Metastatic Non-squamous Non-small Cell Lung Cancer
- Metastatic non-squamous non-small cell lung cancer
- Umezawa Daisuke
- 2024-03-11